EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Volitional control capacity for cough modulation in Progressive Supranuclear Palsy

Michela J. Mir, Justin Childers, Karen Wheeler-Hegland

Journal of Rare Diseases · 16.11.2026 · 5 (1)

DOI: 10.1007/s44162-026-00259-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Rare Diseases, online erschienen am 16.11.2026. Verfasst von Michela J. Mir und 2 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Impaired cough is prevalent in Progressive Supranuclear Palsy (PSP), compromising health in a population at risk for fatal lung infections. Identification of PSP is challenging as symptoms mimic Parkinson disease and Multiple System Atrophy. Characterizing the volitional control capacity of reflexive cough could aid in differential diagnosis and offer insight about the disease impact on cortical modulation of airway functions. This study compared outcomes from two reflex cough conditions (natural vs. suppressed) and hypothesized there would be no differences in reflex cough thresholds or motor output based on PSP effects on substrates governing volitional movement.

Methods

A dose-response randomized block design with 4 concentrations of nebulized capsaicin served as the natural condition (saline control and 50, 100, 150, 200 µM)—participants with PSP coughed if they felt the need. For suppressed reflex cough, increasing doses of capsaicin, up to 400 µM) were administered until cough suppression was not achieved. Cough dose response thresholds, airflow, volume, timing, and urge-to-cough metrics were recorded.

Results

Thirteen individuals with PSP completed the study. For natural and suppressed reflex cough conditions 150µM was the mean capsaicin dose that induced a cough in 2/3 trials ( P = .44); 50µM was the dose that elicited an urge-to-cough ( P =.06). Participants reported a higher urge-to-cough at 200µM during the suppressed cough condition (W = 32; P = .02). There were no differences between natural and suppressed conditions in cough airflow, volume, and timing metrics.

Conclusions

Findings from this study suggest that identification of impaired cough suppression could differentiate PSP from other forms of Parkinsonism and lead to earlier implementation of appropriate medical management and rehabilitation plans. Identifying the capacity for change and rehabilitation is critical, and these data support future research to develop better diagnostic tools and interventions for cough dysfunction. Clinical trial number Not applicable.

Förderung

  • NIH

Zitieren

APA

Mir, M. J., Childers, J., & Wheeler-Hegland, K. (2026). Volitional control capacity for cough modulation in Progressive Supranuclear Palsy. Journal of Rare Diseases, 5(1). https://doi.org/10.1007/s44162-026-00259-2

Vancouver

Mir MJ, Childers J, Wheeler-Hegland K. Volitional control capacity for cough modulation in Progressive Supranuclear Palsy. Journal of Rare Diseases. 2026;5(1). doi:10.1007/s44162-026-00259-2

BibTeX
@article{Mir2026,
  author = {Mir, Michela J. and Childers, Justin and Wheeler-Hegland, Karen},
  title = {Volitional control capacity for cough modulation in Progressive Supranuclear Palsy},
  journal = {Journal of Rare Diseases},
  year = {2026},
  volume = {5},
  number = {1},
  doi = {10.1007/s44162-026-00259-2}
}
Kostenlos starten →